#stayhome Maintain the distance, wash your hands, and follow instructions from the health authorities.
RSS   Newsletter   Contact   Advertise with us

Endo International total revenues $1.24 billion

Share on Twitter Share on LinkedIn
Staff Writer | February 28, 2017
Endo International expects fiscal 2017 earnings per share from continuing operations to be between $0.04 and $0.34, and adjusted earnings per share from continuing operations to be between $3.45 to $3.75.
Endo International
Endo International   Net loss per share was $14.4
The company expects 2017 revenues to range from $3.45 billion to $3.60 billion, and adjusted EBITDA from $1.50 billion to $1.58 billion.

In fiscal 2016, the company's net loss per share was $14.48, adjusted earnings per share were $4.66, and revenues were $4.01 billion.

In its fourth quarter, net loss attributable to the company was $3.34 billion or $14.98 per share, compared to loss of $118.46 million or $0.53 per share last year.

The latest results included $3.5 billion of asset impairment charges associated with the write-down of goodwill and intangible assets primarily related to the Company's Generics reporting unit.

Adjusted earnings per share from continuing operations were $1.77. Total revenues were $1.24 billion, higher than $1.07 billion last year.

Further, the company announced the divestiture of Litha Healthcare Group to Acino for approximately $100 million.

As part of Endo's strategic assessment and comprehensive asset review, Litha no longer aligned with its strategy and was not considered a core asset.